Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

New Non-invasive Modalities for Assessing Retinal Structure and Function

NCT: NCT03475173 · RECRUITING

NCT IDNCT03475173
StatusRECRUITING
Start Date2019-05-06
Completion2028-03-01
SponsorRandy Kardon (OTHER)
First posted
Last updated

Brief Summary

This study investigates a new technology to assess the structure and function inside the eye. Retinal imaging of subjects with inner and outer retinal defects to detect areas of abnormal structure and function compared to other visual function tests.

Frequently Asked Questions

What is New Non-invasive Modalities for Assessing Retinal Structure and Function?

New Non-invasive Modalities for Assessing Retinal Structure and Function is a clinical trial registered under NCT03475173. Current status: RECRUITING.

What is the status of NCT03475173?

The current status of NCT03475173 (New Non-invasive Modalities for Assessing Retinal Structure and Function) is: RECRUITING.

When did New Non-invasive Modalities for Assessing Retinal Structure and Function start?

New Non-invasive Modalities for Assessing Retinal Structure and Function started on 2019-05-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.